This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.
Alumni | RSS | AA | Languages
 

RSS Feeds

RSS Feed - Life Sciences - Transactions - Kaye Scholer LLP

Current Feed: http://www.kayescholer.com/practice/rss.xml?p=life_sciences_transactions

> Change Feed

Kaye Scholer Advises Pfizer in Exclusive Worldwide Licensing Agreement with Gliknik (10/17/14)

Sandoz to Acquire Fougera Pharmaceuticals for $1.5B (10/17/14)

Kaye Scholer Represents Novartis in Agreement with Array BioPharma (10/17/14)

Derek Stoldt (10/16/14)

Derek Stoldt began his practice as a corporate generalist, typically representing private equity funds and their portfolio companies in M&A, securities offerings, joint ventures and other complex contractual transactions. For the past ten years, Derek has focused his practice on representing life sciences and medical technology companies. Derek was named a “Life Sciences Star” in the 2013 and 2014 editions of Euromoney’s LMG Life Sciences.

Seven Kaye Scholer Practices and 15 Individuals Honored in LMG Life Sciences 2014 (09/22/14)

Kaye Scholer Advises Sapheon in its Acquisition by Covidien (08/28/14)

Andres Liivak (08/14/14)

Andres Liivak is the Co-Chair of Kaye Scholer’s Life Sciences Industry Group and a Partner in the firm’s Corporate Department. Working together with the firm’s highly regarded, collaborative, multidisciplinary life sciences team, Andres helps life sciences healthcare industry clients develop comprehensive solutions and manage risk to achieve their business objectives. In his practice, Andres focuses on putting in place new deals as well as counseling with respect to and renegotiating existing transactions, including:

  • Priority, high value deals – examples include in-licenses of blockbuster drugs; acquisitions of target companies and products, including with sales force; divestures of approved products together with supply chain transition; collaborative development and commercialization license arrangements; contentious renegotiation of major commercial contracts relating to key products; and settlement of major IP and contract litigation with business deals.
  • Deals outside a client's comfort zone or recent experience – examples include co-promotion arrangements and companion diagnostic deals.
  • Unusually complex, novel deals – some recent examples include multi-party, multi-product collaborations involving co-development, co-commercialization and exclusive supply arrangements.

Viktoriya Karshenboyem (08/04/14)

Viktoriya Karshenboyem is an Associate in the New York office of Kaye Scholer. She focuses her practice on corporate and finance transactions, including mergers and acquisitions, private equity investments, licensing and collaboration agreements, and securities offerings. She also advises U.S. and international companies, both private and public, on general corporate matters, including corporate governance and securities laws compliance. In addition, Viktoriya advises financial institutions and other borrowers and lenders in the areas of commercial lending and structured finance.

Kaye Scholer’s Frankfurt Life Sciences Team Featured in LMG Life Sciences Europe (07/31/14)

Subscribe

 
 
Practice Practice Groups Industry Groups Regional Groups Pro Bono Professionals Firm Careers Diversity Newsroom Events Offices